The Board will consider two main agenda items:
- Approval and taking on record of the Unaudited Financial Results of the Company for the half year ended September 30, 2026 (H1 of Financial Year 2026-27)
- Consideration of declaration of an interim dividend to the equity shareholders
The company also confirmed that the Trading Window for dealing in the company's securities has been closed since October 1, 2026, in compliance with SEBI's Prohibition of Insider Trading Regulations and the company's Insider Trading Policy. The trading window closure applies to all Designated Persons, their relatives, and Insiders as defined in the policy. The trading window will reopen 48 hours after the announcement of the Unaudited Financial Results.
This information is being disclosed in compliance with Regulation 29(1) and other applicable provisions of the SEBI Listing Regulations and will also be available on the company's website at www.amwillhealthcare.com.